Article
"Mild" hyperphenylalaninemia? A case series of seven treated patients following newborn screening.
Molecular genetics and metabolism - 1 Dec 2017
Viall Sarah, Ayyub Omar, Rasberry Matthew, Lyons Kelly, Ah Mew Nicholas
Abstract excerpt
Hyperphenylalaninemia (HPA) is a disorder diagnosed only incidentally by newborn screening, a by-product of screening for classic phenylketonuria (PKU) which, if untreated, causes irreversible neurologic sequelae. In contrast, HPA is thought to have a benign phenotype because phenylalanine (Phe) levels are insufficiently elevated to cause neurological damage, obviating the need for rigorous dietary protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
